As the population cwlinues lo age, physicians are presenled with the challenge of treating a variety of medical conditions in elderly patients. Suptaventricular tachycardias are the most common form of cardiac arrhythmia and a.lTect all age groups (I). Although usually well tolerated in youth. supraventriculw tachycardias may be associated with disabling symptoms and have lie-threatening potential in the elderly. In additiou, anliarrhylhmic agents are less well tolerated and may be associated with a higher incidence of toxicity in this age group.
The purpose of this study was lo 1) evaluate the &xcy and wfety of radiofrequency calbeter ablation for tbc treatment of supmventricular lachycudia in an elderly (80 years of a& patient group: 2) compare these results with those in patients <70 years of age; and 3) determine the etTect of ablation on subsequent arrhythmia-related hospital care.
Methods
From May 1989 to March 1993.454 patients underwent radiofrequency catheter ablation at the University of California, San Francisco, for the treatment of symptomatic supmventricular tachycardia. Sixty-seven of these patients we= 270 yEaR Of age and fotwilute the study p0pUkiW. Patients underwent one of the following catheter ablation procedures: complete altioventricular (AVI junctional abletion for ventricular rate control in patients with atrial tibrillation, AV node modification for the treatment of AV node reentrant tachycardia, accessory pathway ablation, ablation of the "slow zone" of conduction to cure atrial flutter and coronary artery disease (I:%). and three had a history of ectopic atrial tachycardia ablation. One patient underwent hypertension (33%). Mean ejection fraction in this group was ablation for both AV node reentrant tachycxdia and atrial 60%. A!I panants were severely symptomatic and presented flutter. Arrhythmia-related hospitalizations and emergency with syncope (two patiws), presyncope (six patienls) and room visits were compared for each group before and after congeslive heart failure requiring hospital admission (one the ablation procedure. Nineteen of the patients undergoing patient1 AV junctional ablation and two of the patients undergoing Four patient. underwent ablation for the treatment of AV node modification have been included in two previous atrial flutter (mean age 77 2 4.3 years, range 71 to 81; one reports describing these techniques (2.3). They are described man. three women). These patients were resistant to or here as oart of a consecutive series of aatients. with soecific intolerant of a mean of 3.8 f 0.5 antiarrhvthmic medications. attention to the effects of advanced ke on the s&y and Concomitant organic heart disease was fbund in two patients efficacy of these procedures.
(50%) and included coronary artery disease and diastolic For purposes of comparison we included patients <7O dysfunction. All patients were symptomatic: fatigue and years of age from our previously reported experience. who palpitations (two patients) and presyncope (two patients). underwent complete AQjunctional ablation (35 patients) (2): .4trial tachycardia ablation was pelfarmed in a 73-year AV node modification (33 Patients) (3) and wessorv oath-old woman with five failed antiarrhythmic medications and way ablation (100 patientsj(4) during the same time ~&iod. ao underlying cardiomyopathy (eje&ion fraction JO%). Epi-Patient cbaraeteristia.
Complete AV junctional ablation sodes of atrial tachycardia precipitated congestive heart was perfomted in 37 patients with atrial fibrillation and a failure on several occasions and cardiac arrest on one rapid ventricular response that did not respond to medical occasion. management (mean [+SDI age 76 5 5 years. range 70 to 85: Diagnostic et~t~hy~~ study. All experimental pro-I7 men. 20 women). These oatients were resiasr to or tocols sere approved by the institutional revieew board of the intokrantofameanof5.
I -c I:3 antiarrhythmic medications.

University of Califo&,
San Francisco. and written in-Concomitant organic heart disease was found in 87% of formed consent was obtnined from all patients. In all pathese patients and included coronary artery disease/ tients. except those undergoing complete AV junctional myocardii infarction. rheumatic heart disease and idio-ablation. a standard diagnostic electrophysiologic study was pathic dilated cardiomyowtby, The remaining five patients performed before catheter ablation. dwing the same proce-(13%) had a history of hypertension. Mean ejection frdction dure. Electrode catheters were wsitioned in the hi& right in this group was 50 + 12.6%. and all were severely atrium, right ventricular apex, low septal right atrium and symptomatic: syncope (8 patients), presyncope (14 patients). coronary sinus. Atrial and ventricular incremental pacing congestive hearc ftilwe requiring hospital stay (14 patients) and programmed extrastimulation was performed. Isoproterand car&c arrest (I patient). enol was given if supnventricular tachycxdia could not be Atrioventricuku node modification was aerformed in I7 induced at baseline. Standard criteria for determining the oatients with AV node reentrant tachycaidia (mean age mechanisms of the supraventricular tachycardias were-used ib.8 2 6.3 yews, range 70 to 93: 7 men. 10 women). one (5). wtient also had svmotomatic atrial Butter and underwent Ablation procedures. At attempted ablation sites. 20 to &ative atrial i&r ablation in addition to AV node modi-50 W of unn&Julated radiof?equency energy (EP Technolohation (see later). These patients were resistant to or gies) was delivered between the distal electrode of the intdetantofamettn of4.3 t 1.4antiarrhythmic medications. ablation catheter and a large-diameter skin patch electrode.
Concomitant organic heart disease was found in 33% of
Unless otherwise noted, a 7F or 8F tipdeflecting bipolar or these patients and included coronary artery disease, atria1 quadmpolar catheter with a 4. or S-mm distal electrode (EP satal defect and mitral valve orolaose. In addition. 33% of Technolocies or Mansfield/Webster) was used as the ablapatients had a history of hype~ensi~n. Mean ejectbo frac-tion catheter. lion in this group was 57.1 + '.7%. All patients were Alrioventricular jun&nal ablation. A standard 6F biposeverely symptomatic: syacope (2 patients), presyncop-(I3 lar electrode catheter was introduced through the right patients) and congestive heart failure requiring hospital femoral vein and advanced to the apex of the right ventricle admission (2 t&ems). to serve as a temporary pacemaker. As previously described Ablation dfan accessory AV pathway was performed in (2). an ablation catheter was also introduced through the nine patients (mean age 72.7 c 2.8 years. iange 70 to 77; right femoral vein and advanced across the tricuspid annulus three men. six women). These patients were resistant to or to the region of the His bundle. Before October 1990. in the intolerant ofa mean of 4. I -C 0.0 antiarrhythmic medications. initial 16 patwnts a custon~, non-tip-deflecting ablation cath-Accesson, oathwav conduction was manifest in seven pa-eter with a 3.mm distal electrode was used. Ablation was tients and &e&d in two. Disopyramide therapy resulied attempted at the site recording the maximal His bundle in cardiac arrest due to polymorphous ventricular tachycardia in one patient. and encainide therapy resulted in ventricular tachycardia in another. One patient had concomitant potential, with a procedural end point ofcomplete AV biock. If complete AV block was maintained for 30 min the patient was redraped and prepared, and a permanent pacemaker was implanted. Before 1991, ifcomplete AV block could not be achieved with radiofrequency energy, ablation with direct current energy was attempted, as previously described (2). Alrlnventrkular @ode modIli&nu.
In the initial live patients with AV node reentrant tachycardia, selective ablation of the fast AV node pathway was pafomwl, as previously described (6). Procedural end points were the noniuducibil-ityofAV node reenttant tachycardiaand aH)%prolongation of the PR interval or retrograde ventriculoahial block, or both.
In the subsequent 12 patients, selective ablation of the slow AV node pathway was performed (3). The procedural end point was either absence of evidence of dual AV node physiology attd no AV node reentrant echw or alteration of slow pathway conduction such that no more than a single AV node reentrant echo was present.
Aewwry pathway nbMbu. After determination of the sites in the right atrium. Endocardial activation at each site was compared with the onset of the P wave recorded on the surface leads. Procedural end points were the termination of atrial tachycardia with energy application and the noninducibiitv of tachyadia despite atrial overdrive pacing (to cycle length 100 m$ and prog&med stimulation (up to-two atrial extrastimuli) in the presence and absence of isapmterenol. approximate location of the accessory pathway, the ablation catheter was positioned rdonn the mitral or tricuspid annu-Ius, BE previ&ly dercribed(4). For left-sided &cessory pathways, the mitral annulus was reached using a retro@adc arterial approach, with the ablation catheter positioned on the ventricular side of the mitral valve apparatus, or a transeptrdapproach, withtheablation catheterpositioned on the atrird aspect of the mitral annulus. During mapping and ablation in the systemic circulation, patients &e-&ent full anticougulation with intravenous heparin. For tight-sided access&y pathways, u transvenou~ approach t&ugh a femoral vein was used to position the catheter on the attial wect of the tricuspid annulus. Ablation was attempted at siies that recorded ihe shortest ventrictdnr to atrial'activalion times during orthodmmic reciprocating tachycardii or fusion of the local atrial and ventricular electrograms during sinus rhythm, or both, in patients with ventricular pnexcitation. Procedural end points were the elimination of both anterogrude and retmgrade accessory pathway conduction.
AtrIal Ilulter nhktkm. In four patients. type I (classic) atrial flutter wns diamtosed durine the baseline studv 17.8). The site of ablation &s determined anntomically &g'ri&t and left anterior oblique Ruoroscopic projections. Initial ablation attempts were made in the posterior septal space in the region between the ostium of the coronary sinus and septnl leaflet of the tricuspid valve. If unsuccessful, the ablation catheter was repositioned to the postemlateral right atrium, in the region between the inferior vcnn cavn and tricuspid annulus, and abiation was reattempted. Procedural end points were the termination of tachycardia with energy andication and the noninducibilitv of atrial flutter desoite &al overdrive pacing (to cycle length 100 ms) and programmed stimulation (up to two attial extrastimuli) in the presence and absence of isoproterenol.
AtrW tachycardka ab~tino. After diagnostic study in the one patient with r&l tachycwdia. mapping was perfornaed with the ablation catheter during atrial tachycardia to determine the onset of endocardinl atrial activation at various F&low-up. After the ablation procedure all patients were admitted ovemight to a telemeCry unit and underwent continuous ekctrocardiographic (ECG) monitoring for at least 24 h. All patients had a padischarge echocardiogram and 12-M ECG; 24h ambulatory ECG monitoring v/as performed --I month after the ablation procedure.
SuLaierl rBelh&. values are reported as rtlcan value * SD. Statistical analysis was performed using analysis of variance and chiaquare analysis. and p L 0.05 was considered significant.
ReMllts
AtrIweWkalu
ImwtImal abIM&m. Cosulete heart block war achieved b all 37 patients ucdergoi& AV junctional ablation. In 34 patients (92461, mdiincy energy alone was used. A mean of 4.2 2 3.2 mdiitiwuenc~ applications were delivered in these patients. Early io Wr experience direct current energy was requ&d in three patients (6%). There were uo complications at th+ time &he ablatiou procedure, and there were no early deaths (within 1 month of the ah&tion prwdure).
In &dditiM. echocardi~ gmmr perfwmcd before ho&+itaI discharge rcveakd ml new v&ular or myocmdiai abwmalities. Gne patient had a nonfatal puImonary embolus 3 days 8flcr hospital discbarge. Therefore, the ovemll ¶uccess rate was 10096. with a Eomplication rate of 3%.
Tllere were four deaths (11%). acurring at a mean of 24 t IO months alter the ablation procedure. Two patients died of pmstate cancer; one patient had a fatal ccrebmvascular a&lent:
and one patient was found dead at home. Themfore, a cardiac cause of death may have been present in only one patient (2.7%). The remaining 34 fatients (I@%) had P mean folhwup of25.3 * 10.6 months (runge 8 to 52). Atrioventdcular conduction returned in one patient (3%). but the fentticular response WIU signitiwtly slower then hefore ablation. These patients all report improved quality of lie and are no longer taking sntiarrhythmic agents for the control of ventricular note.
In a recent repoti we descrihcd our experience in patknts undergoing AV junctional ablation using direct current and radiofrequency energy (2). Radiofrequeney was the initial energy choice in 54 patients. Gf this group, 19 patients were 270 years of age and are included in the results dewihed cwlier. The remaining 35 younger patients formed the control group (Table I) , and the study group was signiticantly olde; than the control group (75.6 + 4.5 vs. 51.9 + 13.7 years, p = O.twJI). However, there were no diiTerences with respect to gender, number o: antiarrhythmic agents tried. ejection fraction, success utilizing radiofrequency energy. number of radiofrequency applications required or complications between the two groups. Three patients died, and conduction retortted in two patients in the contml group duriw follow-up. This was similar to the results in the study kmi cnrauve #)lrdlm for ttwdment of sop~ven~~ ~&~ardia.
An ablative procedure to cure supraventricular tachycardia WBS attempted in 30 patients. The overall SKcess rate was 97% (30 of 31 orocedwes in 29 of 30 ratients). There were no p~edo&lated deaths, and thi overall complication rate ~85 13% (4 of 30 patients). The details of each pnxedore are presented next.
Abkratrln3rmde t&if&&m. Atrioventticular node reentmttt tachycardia was cured in all 17 patients undergoing AV oode mod&&n.
In the first five patients. successful selective ablmion of the fast AV node &way was achieved with a mean of 5.8 f 4.9 radiofrequ&cy applications. All five Datients had resttltrmt tirst-deeree AV block. In fhe subs&tent 12 pr&nts, selective &don of the slow AV weal pathway was achieved in II patients with a mean of 5.6 + 6.6 radiofrequency energy applications. In the one remaining prdient a vcntrictdar triplet during energy application caused Ihc ablation catheter to move abruptly to the His bundle region. Although the energy application was immediaelv temtinsted. comoletc heart bkxk was uroduced. lIten were no other m~plications or early deaths. Therefore. control of arrhythmia was achieved in IW% of patients, with a sttccess mte of 94% and a complication rate of 6%.
One patient with severe chronic obstructive pulmonary disease died of nspimtory arrest unrelated to cardiac disease 38 months after his ablation pmcedure. Before death tlte patient reported 110 arrhythmia recurrences and was not &king arty mdiarrhytbmic agents. The remaining I6 patients (94%j had a mean follow-up of 19.3 t 15.5 months (range 5 to 50). The oetient with complete heart block had a dual-&m&r, pe&ent pacem&r implanted on the day of his ablation pmcedere sod repons no symptoms or limitations dariog follow-up. The remaining patients all report improved quality of life. no arrhythmia recurrences and are not taking any sntiarrhyfhmic agent
In a recent report we described our results in 35 patients undergoing selective ablation of the slow AV node pathway for the treatment of AV node ~centram tachycwdia (3). Two of these patients were described earlier. The remaining 33 patients served as the control group (Table 2 ). The study group was significantly older than the control group (76. I 2 4.7 vs. 43.2 + IS. p = O.CGQl). In addition. the study group received significantly more antiarrhythmic medications (4.3 ? 1.4 vi. 2.0 C i.0, p = 0.0001). The two groups were similar with regard to gender, success, number of radiofrequency applications required, complications. recurrences and deaths during follow-up.
Accessory pathway shlatieo. Successful ablation of a single accessory pathway was achieved in all nine patients with a mean of lo.0 f 9.0 radiofrequency energy applications. Seven patients had lefi free wail accessory pathways (live lateral, two anterolaterall, and two patients had septal accessory pathways (one right posteroseptal, one letI intermediate septol). In the eight patients with left-sided pathways, a transseptal approach wes utilized in six and a retrograde aortic approach in two. There were two procedure-related complications. One 74.year old man undergoing ablation of a left-sided accessary pathway through a tmnssepti approach developed B pericardial effusion with early signs of cardiac tampanade immediately after the procedure. A pericardiocentesis was performed. and the patient made an uneventful recovery. In lhis patient technical difficulties led to extensive manipulation of the right ventricular catheter. In addition. one 70.year old woman. alsa undergoing ablation of a left-sided accessory pathway through a transseptal ap praach. developed pericardird pain and a new rub after the procedure. Echocardiography revealed no pericardial etlusion, and the patient had an uneventful recovery. There were no early deaths in this patient group. Therefore. the overall success nte was IW%. with B major complication rate of II% and an overall complication &te of 22%.
There have been no deaths or recurrences of accessory pathway conduction during B mean fallow-up period d I4 + 9 manths (range 5 to 27). Two patients have continued antiarrhythmic medications (quinidine in one, amiadamne in one) for the treatment of atrial fibrillation. All patients report significantly improved qualily of life.
In B recent report we described our experience in 100 consecativc patients (all ~70 years old) undergoing accessory pathway ablation using rxiiofrequency energy (4). These patients comprised the control group (Table 3) . The sludy group ws significantly older than the conlral group (72.7 f 2.8 vs. 31.0 f 15.7 yews, p = O.OGIII) . In addition, the study group received significanlly more antiarrbythmic medications (4.1 ? 0.8 vs. 2.0 t 1.5. D = O.WJl) . There were tta differences with respect to gender. ejection fraction, number of radiofrequency applications required or saccess between the two groups. However, there were significantly mare complications in the study graup (22% vs. 4%, p = 0.02). Spcciticzally. I (2%) of the 60 younger and 2 (25%) of the 8 oldet patients with!-' ,._ed accessory pathways had a cardiac perforation (p = O.MS).
Atrial flutter &Mon. Atrial flutter was successfully ablated in all four patients, with a mean of 11.3 + 6.3 mdiofreauency armlications. The site of successful ablation was past&ose~t~ in three patients and ponteralateral in one. One patient, who also underwent intracardiac ultrasound imaging that required the insertion of an additional IOF femoral sheath (91, developed a deep vemus thrombosis. This patient war treated with intravenous and then oral anticoagulant agenis and made an uneventful recovery. During a-follow-up 69.0 t 4.2 months (range 5 to ISI. na patient required antiarrbyihmic therapy. and there were na arrhythmia recurrences.
Atrial tubyardh &htia.
In one patient the atrial tachycurdia focus was mapped to the base of the right atrial a~wndwe.
Endowdial activstian at this site preceded the s&cc p wave by 60 ms. Atrial tachycardii w& temdnated during the fifth mdiafreqaeney energy applicatian and remained nanindaciblc in the presence and absence of isoproterenol. Tkre were no complications. The patiant has remained arrhythmia free for 9 months. with no anttifihrnic mediation. 
r3i%?ussion
Ruaik.
Although B small number of elderly patients undergoing radiofrequency catheter ablatian for the treatment of supwentricalar arrhythmias have been included in pwiaus descriplions of ;Iblation praceduras (2.3.10-14). this is the first report to evaluate the safety and etlicacy of radiifrequency catheter ablation ~pecitically in a large graup of elderly patients. F'roccdural end paints were achieved in 61 of 68 ablation procedures. resulting in an ovemll success rate of 98.5%. There were DO procedure-related or early deaths. The overall comr4ication rate was 7.4%. and only one patient (MS) had k&g.term sequelae (permanent cardiac pacing for complete heart block). At a mesn fallow-up of 22.1 f 12.9 months (range 5 to 52). 63 (N%) of67 patients were alive, with no an&rhythmic agents for the treatment of their presentiog arrhythmia.
Complieatitms. Elderly patients undergoing complete AV junctional ablation and AV node modification had a low complication rate, similar to that in younger patients. However. we found a higher incidence of cardiac perforation in older patients undergoing ablation of left-sided accessory pathways. Although we were unable to determine the chamher perfotaued, we suspect that the right ventricle was involved. In one patient. technical difficulties led to extensive manipulation of the right ventricular catheter. In snorher patient, the lack of accumulation of peticardial bled made oafomtion of the lefl atrium less likely. A small quickly L response to ventricular contraction, as opposed to continued leaking t?om atrial chambers. It is possible that perfotadons occur more often than suspected and that they become clinically manifest in left-sided procedures because of the adminislration of heratin. In addition. an age-related increase in stiffness and a decrease in thickness of the right ventricular wall may increase the risk of perforation in the elderly (15.16). Therefore, although care should always be taken when manipulating catheters in the heat. this is espceially uue in elderly patients. A pulmonary embolos occured in one patient (I 5%). We do not routinely petfonn anticoagulation in patients undergoing tight-sided procedures. Anticoagulation would ioemase Ihe risk of bleeding and cardiac tampontide. Further study is required to determine whether the benefits of anticoa&tion would outweigh the risks. swpnve&kahrta&yardbil4thedtkrly.
Thecobortof p4atls with paroxysmal suptaventticular tachycardias other than atrial fibrillation was relatively healthy with good IeH ventrietdar function. However, episodes of txhycdia were assaekted with severe symptoms in most patients. This apparent inconsistency can be explained by age-related SbmKmnlities in diastolic relaxation and Mittg, resulting in a tachycadia-iiuced reduction in cardiac output, even in the absence of d&ax (17~201. In addirion. because of axerelated impairment if cardiovascular reflexes and an 1. erased likelihood of cerebmvawtlar disease. elderly patieas are more likely IO have tt critical reduction in cerebral Row during tschycardic episodes ;,?I).
Taehywdic episodes we not only less well tolerated in elderly &ent.s. they appear to occur more frequently. In a recent study advancing age was found to be the most impoztanl factor in determining the frequency of spontaneotts episodes of symptomatic atrial fibrillation and paroxysmal supaventricular tachycardis (22). Each I&year increment in age was associated with a 25% decrease in the time 10 lirst reewrettee. Therefore, a 70-year old patient would have twice the frequency of arrhythmic events as a @year old @e.nt. &cause of age-related physiologic changes and a higher likelihood ofcoexisting diseases, ant&rhythmic agents may be kss well tolerated and produce more toxicity in elderly patients ( Table 5 ). These physiologic changes pmducc alterations in the volume of distribution, protein binding and clearance of antiarrhythmic agents. leading to increased risk of tonicity (23-26). In addition, impaimtent of cardiovascular reflexes and co&sting myocwdii dysfunction potentiatas the hypotensivc effects of agents with vasodilating and nep&ive ionotmpic propelties (?I). In addition. it has been postulated that myocardial sensitivity to antiarrhythmic agents may be altered in the elderly (27-29).
Despite these findings there appears to be a reluctaoce 10 offer invasive treatment options to elderly patients with symptomatic supraventricuiar tachycardia.. In our series, elderly patients with accessory pathway mediated end AV node reentrant tachyctudia received significantly more antiarrhythmic agents than younger patients. Although this may be due in part to a longer history of tachycardia and limited treatment options in previous yeas, it also may be related to a reluctance to subject elderly patients to inwive procedures.
The number of arrhythmia-related hospital admissions and emergency mom visits per year were dramatically decreased after ablation in all patient groups. Given the cost of repeated hospital admissions. emergency room and clinic visits and long-tcnn antiarrhythmic therapy. catheter ablation may be a cost-effective as well as safe. and efficacious treatment option. ~tudyliiitatiiaa. Themajorlimitationofthisstudyisthe small number of patients in some of the subgroups. Although ctttheter ablation appeared to be an effective and safe treatment option for elderly patients in this series, further study is required of the more infrequent procedures. In addition, although in these patients a signiticant number of antiarrhvthmic awnis failed. they rcquired significantly less health c&e after ablation. However, this study did not compare medical and ablative therapy. A carefully designed, randomized, prospective study is required to resoiie this point.
Conehuiotts. In this series, radiofrequency catheter ablation appears to be an effective and safe treatment option in elderly patients (270 years old) with a variety of symptomatic. drug-resistant supraventricular tachycardias. Because of the high incidence of severe symptoms associated with tachycardic episodes and the intolerance and toxicity associated with antiarrhythmic medications in this group, catheter ablation might be considered an early rather than a last resort lreatment option. Further prospective, raudmnized trials are needed tohemonstrate whether medical or ablative therapy is most beneficial with regard to efficacy, toxicitg and MS,.
